Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
- 31 December 2006
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 103 (3), 797-801
- https://doi.org/10.1016/j.ygyno.2006.08.047
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm TrialJNCI Journal of the National Cancer Institute, 2003
- Patients with ovarian carcinoma upstaged to Stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patientsCancer, 1998
- Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma: A proposal for essential sites for lymph node biopsyCancer, 1996
- Cytoreductive Surgery in Advanced Epithelial Cancer of the Ovary: The Impact of Aortic and Pelvic LymphadenectomyGynecologic Oncology, 1995
- Ovarian cancer staging: Does it require a gynecologic oncologist?Gynecologic Oncology, 1992
- Survival of ovarian carcinoma with or without lymph node metastasisGynecologic Oncology, 1987
- AnnouncementGynecologic Oncology, 1986
- Aortic lymph node metastases in early ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1974